Statin Use is Associated With Reduced Risk of Histologic Subtypes of Esophageal Cancer:a Nested Case-Control Analysis

Alexandre, Leo, Clark, Allan B, Bhutta, Hina Y, Holt, Sean, Lewis, Michael Pn and Hart, Andrew R (2014) Statin Use is Associated With Reduced Risk of Histologic Subtypes of Esophageal Cancer:a Nested Case-Control Analysis. Gastroenterology, 146 (3). 661–668. ISSN 0016-5085

[img] Microsoft Word (acceptance e-mail) - Submitted Version
Download (15kB)

    Abstract

    Most patients with esophageal adenocarcinoma (EAC) or squamous cell cancer (ESCC) present with advanced, incurable disease. Statins have reported anti-carcinogenic effects and may be chemoprotective. We investigated the association between regular use of statins and the main histologic subtypes of esophageal malignancy (EAC, esophagogastric junctional adenocarcinoma [EGJA], and ESCC) in the UK general population.

    Item Type: Article
    Additional Information: Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.
    Uncontrolled Keywords: esophageal cancer,statins,aetiology
    Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
    Depositing User: Pure Connector
    Date Deposited: 20 Jan 2014 15:54
    Last Modified: 21 Mar 2019 11:03
    URI: https://ueaeprints.uea.ac.uk/id/eprint/46092
    DOI: 10.1053/j.gastro.2013.11.046

    Actions (login required)

    View Item